Bristol-Myers Squibb
BMY
BMY
2,536 hedge funds and large institutions have $111B invested in Bristol-Myers Squibb in 2023 Q1 according to their latest regulatory filings, with 128 funds opening new positions, 1,050 increasing their positions, 1,011 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
7% less first-time investments, than exits
New positions opened: 128 | Existing positions closed: 137
2% less funds holding
Funds holding: 2,596 → 2,536 (-60)
9% less funds holding in top 10
Funds holding in top 10: 75 → 68 (-7)
Holders
2,536
Holding in Top 10
68
Calls
$1.6B
Puts
$1.03B
Top Buyers
| 1 | +$614M | |
| 2 | +$335M | |
| 3 | +$302M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$272M |
| 5 |
BlackRock
New York
|
+$201M |
Top Sellers
| 1 | -$692M | |
| 2 | -$303M | |
| 3 | -$191M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$170M |
| 5 |
Morgan Stanley
New York
|
-$145M |